ClinicalTrials.govpublic full text
SBRT With Cetuximab +/- Docetaxel Followed by Adjuvant Cetuximab +/- Docetaxel in Recurrent, Previously-Irradiated SCCHN
previously-irradiated, squamous cell carcinoma of the head and neck cancer, stereotactic body radiation therapy (sbrt), interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 864406
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.